Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction FREE

Vera Bittner, MD; Debra H. Weiner, MPH; Salim Yusuf, MBBS, DPhil; William J. Rogers, MD; Kevin M. McIntyre, MD; Shrikant I. Bangdiwala, PhD; Marvin W. Kronenberg, MD; John B. Kostis, MD; Robert M. Kohn, MD; Maureen Guillotte, RN; Barry Greenberg, MD; Patricia A. Woods, RN; Martial G. Bourassa, MD

[+] Author Affiliations

A complete list of the SOLVD investigators may be found in Bangdiwala SI, Weiner DH, Bourassa MG, Friesinger GC II, Ghali JK, Yusuf S, for the SOLVD Investigators. Studies of Left Ventricular Dysfunction (SOLVD) Registry: rationale, design, methods and description of baseline characteristics. Am J Cardiol. 1992;70:347-353.

Reprint requests to Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, THT 328-UAB Station, Birmingham, AL 35294 (Dr Bittner).

JAMA. 1993;270(14):1702-1707. doi:10.1001/jama.1993.03510140062030

Text Size: A A A

Published online

Article

References

ABSTRACT

ABSTRACT | REFERENCES

Objective. —To study the potential usefulness of the 6-minute walk test, a self-paced submaximal exercise test, as a prognostic indicator in patients with left ventricular dysfunction.

Design. —Data were collected during a prospective cohort study, the Studies of Left Ventricular Dysfunction (SOLVD) Registry Substudy.

Setting. —Twenty tertiary care hospitals in the United States, Canada, and Belgium.

Participants. —A stratified random sample of 898 patients from the SOLVD Registry who had either radiological evidence of congestive heart failure and/or an ejection fraction of 0.45 or less were enrolled in the substudy and underwent a detailed clinical evaluation including a 6-minute walk test. Patients were followed up for a mean of 242 days.

Outcome Measures. —Mortality and hospitalization.

Results. —During follow-up, 52 walk-test participants (6.2%) died and 252 (30.3%) were hospitalized. Hospitalization for congestive heart failure occurred in 78 participants (9.4%), and the combined endpoint of death or hospitalization for congestive heart failure occurred in 114 walk-test participants (13.7%). Compared with the highest performance level, patients in the lowest performance level had a significantly greater chance of dying (10.23% vs 2.99%; P=.01), of being hospitalized (40.91% vs 19.90%; P=.002), and of being hospitalized for heart failure (22.16% vs 1.99%; P<.0001). In a logistic regression model, ejection fraction and distance walked were equally strong and independent predictors of mortality and heart failure hospitalization rates during follow-up.

Conclusion. —The 6-minute walk test is a safe and simple clinical tool that strongly and independently predicts morbidity and mortality in patients with left ventricular dysfunction.(JAMA. 1993;270:1702-1707)

REFERENCES

ABSTRACT | REFERENCES

Kannel WB, Belanger AJ. Epidemiology of heart failure . Am Heart J . 1991;;121:951-957.

Braunwald E. Examination of the patient . In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine . 4th ed. Philadelphia, Pa: WB Saunders Co; 1992;:11-12.

Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol . 1981;;47:33-39.

Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM. Two, six, and 12 minute walking tests in respiratory failure. BMJ . 1982;;284:1607-1608.

Knox AJ, Morrison JFJ, Muers MF. Reproducibility of walking test results in chronic obstructive airways disease. Thorax . 1988;;43:388-392.

Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6 minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J . 1985;;132:919-923.

Lipkin DP, Scriven AJ, Crake T, Poole-Wilson PA. Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ . 1988;;292:653-655.

Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax . 1984;;39:818-822.

Guyatt GH, Thompson PJ, Berman LB, et al. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis . 1985;;38:517-524.

The SOLVD Investigators. Studies of left ventricular dysfunction (SOLVD): rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol . 1990;;66:315-322.

Bangdiwala SI, Weiner DH, Bourassa MG, Friesinger GC, Ghali JK, Yusuf S, for the SOLVD Investigators. Studies of Left Ventricular Dysfunction (SOLVD) Registry: rationale, design, methods and description of baseline characteristics . Am J Cardiol . 1992;;70:347-353.

Jafri SM, Lakier JB, Rosman HS. Symptoms and tests of ventricular performance in the evaluation of chronic heart failure. Am Heart J . 1986;;112:194-196.

Franciosa JA, Ziesche S, Wilen M. Functional capacity of patients with chronic left ventricular failure. Am J Med . 1979;;67:460-466.

Dunselman PHJM, Kuntze CEE, van Bruggen A, et al. Value of New York Heart Association classification, radionuclide ventriculography, and cardiopulmonary exercise tests for selection of patients for congestive heart failure studies. Am Heart J . 1988;; 116:1475-1482.

Baker BJ, Leddy C, Galie N, Casebolt P, Franciosa JA. Predictive value of M-mode echocardiography in patients with congestive heart failure. Am Heart J . 1986;;111:697-702.

Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic implications of exercise capacity in chronic congestive heart failure. Am J Cardiol . 1985;;55:1037-1042.

Cohn JN, Rector TS. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol . 1988;;62:25A-30A.

Gibbs JSR, Keegan J, Wright C, Fox KM, Poole-Wilson PA. Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol . 1990;;15:52-61.

Meiler SEL, Ashton JJ, Moeschberger ML, Unverferth DV, Leier CV. An analysis of the determinants of exercise performance in congestive heart failure. Am Heart J . 1987;;113:1207-1217.

Willens HJ, Blevins RD, Wrisley D, Antonishen D, Reinstein D, Rubenfire M. The prognostic value of functional capacity in patients with mild to moderate heart failure. Am Heart J . 1987;;114:377-382.

Cohn JN, Archibald DG, Francis GS, et al. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. Circulation . 1987;;75( (suppl IV) ):49-63.

Gradman A, Deedwania P, Cody R, et al. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol . 1989;; 14:564-570.

Cohn JN, Johnson G, Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction: the V-HeFT Study. Circulation . 1990;;81( (suppl III) ):48-53.

The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med . 1991;;325:293-302.

Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med . 1991;;325:303-310.

Franciosa JA. Why patients with heart failure die: hemodynamic and functional determinants of survival. Circulation . 1987;;75( (suppl IV) ):20-27.

Griffin BP, Shah PK, Ferguson J, Rubin SA. Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am J Cardiol . 1991;;67:848-853.

Rozkovec A, Papouchado M, James MA, Kendrick AH, Clarke LM, Rees LR. The relationship of symptoms to performance in paced patients with breathlessness. Eur Heart J . 1989;;10:63-69.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal